Annual CFF
-$4.17 M
+$1.32 M+24.05%
31 December 2023
Summary:
Utah Medical Products annual cash flow from financing activities is currently -$4.17 million, with the most recent change of +$1.32 million (+24.05%) on 31 December 2023. During the last 3 years, it has risen by +$6.57 million (+61.20%). UTMD annual CFF is now -123.04% below its all-time high of $18.08 million, reached on 31 December 2011.UTMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
30 September 2024
Summary:
Utah Medical Products quarterly cash flow from financing activities is not available.UTMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
30 September 2024
Summary:
Utah Medical Products TTM cash flow from financing activities is not available.UTMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTMD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.1% | - | - |
| 3 y3 years | +61.2% | - | - |
| 5 y5 years | +12.8% | - | - |
UTMD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.8% | ||||
| 5 y | 5 years | at high | +61.8% | ||||
| alltime | all time | -123.0% | +70.3% |
Utah Medical Products Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.19 M(+80.5%) | -$13.28 M(+87.1%) |
| Mar 2024 | - | -$3.98 M(+271.9%) | -$7.10 M(+70.4%) |
| Dec 2023 | -$4.17 M(-24.1%) | -$1.07 M(+3.5%) | -$4.17 M(+3.8%) |
| Sept 2023 | - | -$1.03 M(+2.5%) | -$4.01 M(+0.1%) |
| June 2023 | - | -$1.01 M(-3.7%) | -$4.01 M(-38.8%) |
| Mar 2023 | - | -$1.05 M(+14.0%) | -$6.55 M(+19.5%) |
| Dec 2022 | -$5.48 M(-49.7%) | -$920.00 K(-10.9%) | -$5.48 M(-56.6%) |
| Sept 2022 | - | -$1.03 M(-70.9%) | -$12.63 M(+1.5%) |
| June 2022 | - | -$3.55 M(<-9900.0%) | -$12.45 M(+25.3%) |
| Mar 2022 | - | $19.00 K(-100.2%) | -$9.94 M(-8.9%) |
| Dec 2021 | -$10.90 M(+1.6%) | -$8.07 M(+849.4%) | -$10.90 M(+188.7%) |
| Sept 2021 | - | -$850.00 K(-18.0%) | -$3.78 M(-12.1%) |
| June 2021 | - | -$1.04 M(+9.2%) | -$4.29 M(+0.8%) |
| Mar 2021 | - | -$949.00 K(+0.7%) | -$4.26 M(-60.3%) |
| Dec 2020 | -$10.73 M(+153.9%) | -$942.00 K(-31.1%) | -$10.73 M(-0.3%) |
| Sept 2020 | - | -$1.37 M(+36.3%) | -$10.76 M(+3.8%) |
| June 2020 | - | -$1.00 M(-86.5%) | -$10.37 M(-3.2%) |
| Mar 2020 | - | -$7.42 M(+665.7%) | -$10.72 M(+153.5%) |
| Dec 2019 | -$4.23 M(-11.5%) | -$969.00 K(-0.7%) | -$4.23 M(-22.5%) |
| Sept 2019 | - | -$976.00 K(-27.8%) | -$5.45 M(+1.1%) |
| June 2019 | - | -$1.35 M(+45.4%) | -$5.39 M(+11.3%) |
| Mar 2019 | - | -$930.00 K(-57.6%) | -$4.85 M(+1.5%) |
| Dec 2018 | -$4.78 M(+80.1%) | -$2.19 M(+139.1%) | -$4.78 M(+36.9%) |
| Sept 2018 | - | -$918.00 K(+13.9%) | -$3.49 M(-0.3%) |
| June 2018 | - | -$806.00 K(-6.1%) | -$3.50 M(-1.8%) |
| Mar 2018 | - | -$858.00 K(-5.5%) | -$3.56 M(+34.3%) |
| Dec 2017 | -$2.65 M(-58.2%) | -$908.00 K(-2.3%) | -$2.65 M(-58.8%) |
| Sept 2017 | - | -$929.00 K(+6.9%) | -$6.44 M(0.0%) |
| June 2017 | - | -$869.00 K(-1739.6%) | -$6.44 M(+0.0%) |
| Mar 2017 | - | $53.00 K(-101.1%) | -$6.43 M(+1.5%) |
| Dec 2016 | -$6.34 M(-28.7%) | -$4.69 M(+405.1%) | -$6.34 M(+79.6%) |
| Sept 2016 | - | -$929.00 K(+7.2%) | -$3.53 M(-11.1%) |
| June 2016 | - | -$867.00 K(-685.8%) | -$3.97 M(-2.1%) |
| Mar 2016 | - | $148.00 K(-107.9%) | -$4.05 M(-54.4%) |
| Dec 2015 | -$8.89 M(+7.6%) | -$1.88 M(+37.5%) | -$8.89 M(-9.5%) |
| Sept 2015 | - | -$1.37 M(+44.0%) | -$9.83 M(-6.4%) |
| June 2015 | - | -$951.00 K(-79.7%) | -$10.50 M(-14.3%) |
| Mar 2015 | - | -$4.69 M(+66.4%) | -$12.26 M(+48.4%) |
| Dec 2014 | -$8.26 M(+25.2%) | -$2.82 M(+37.9%) | -$8.26 M(+1.9%) |
| Sept 2014 | - | -$2.04 M(-24.5%) | -$8.11 M(+4.6%) |
| June 2014 | - | -$2.71 M(+289.9%) | -$7.75 M(+14.9%) |
| Mar 2014 | - | -$694.00 K(-74.0%) | -$6.75 M(+2.3%) |
| Dec 2013 | -$6.60 M(-40.9%) | -$2.67 M(+57.8%) | -$6.60 M(-11.5%) |
| Sept 2013 | - | -$1.69 M(-0.8%) | -$7.45 M(-11.2%) |
| June 2013 | - | -$1.70 M(+212.9%) | -$8.40 M(-15.1%) |
| Mar 2013 | - | -$544.00 K(-84.5%) | -$9.89 M(-11.5%) |
| Dec 2012 | -$11.17 M(-161.8%) | -$3.52 M(+33.8%) | -$11.17 M(-3.6%) |
| Sept 2012 | - | -$2.63 M(-17.7%) | -$11.59 M(+0.8%) |
| June 2012 | - | -$3.20 M(+75.3%) | -$11.50 M(+8.5%) |
| Mar 2012 | - | -$1.82 M(-53.7%) | -$10.59 M(-158.6%) |
| Dec 2011 | $18.08 M(-381.6%) | -$3.94 M(+55.4%) | $18.08 M(+2.5%) |
| Sept 2011 | - | -$2.54 M(+10.6%) | $17.64 M(-6.7%) |
| June 2011 | - | -$2.29 M(-108.5%) | $18.90 M(-5.8%) |
| Mar 2011 | - | $26.85 M(-712.7%) | $20.06 M(-412.5%) |
| Dec 2010 | -$6.42 M(+70.3%) | -$4.38 M(+244.8%) | -$6.42 M(+72.3%) |
| Sept 2010 | - | -$1.27 M(+12.0%) | -$3.73 M(+12.9%) |
| June 2010 | - | -$1.14 M(-407.6%) | -$3.30 M(+3.2%) |
| Mar 2010 | - | $369.00 K(-121.8%) | -$3.20 M(-15.1%) |
| Dec 2009 | -$3.77 M(-72.6%) | -$1.69 M(+99.6%) | -$3.77 M(-62.6%) |
| Sept 2009 | - | -$846.00 K(-18.1%) | -$10.09 M(-8.9%) |
| June 2009 | - | -$1.03 M(+411.4%) | -$11.08 M(-8.4%) |
| Mar 2009 | - | -$202.00 K(-97.5%) | -$12.09 M(-12.2%) |
| Dec 2008 | -$13.77 M(+113.7%) | -$8.01 M(+337.8%) | -$13.77 M(+82.7%) |
| Sept 2008 | - | -$1.83 M(-10.6%) | -$7.54 M(+6.0%) |
| June 2008 | - | -$2.05 M(+8.7%) | -$7.11 M(+4.1%) |
| Mar 2008 | - | -$1.88 M(+6.0%) | -$6.83 M(+6.0%) |
| Dec 2007 | -$6.45 M | -$1.78 M(+26.6%) | -$6.45 M(+3.8%) |
| Sept 2007 | - | -$1.40 M(-20.6%) | -$6.21 M(+3.7%) |
| June 2007 | - | -$1.77 M(+18.3%) | -$5.99 M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$1.50 M(-2.9%) | -$6.43 M(-20.9%) |
| Dec 2006 | -$8.13 M(+42.9%) | -$1.54 M(+30.4%) | -$8.13 M(+79.5%) |
| Sept 2006 | - | -$1.18 M(-46.7%) | -$4.53 M(-12.7%) |
| June 2006 | - | -$2.21 M(-30.6%) | -$5.18 M(-28.5%) |
| Mar 2006 | - | -$3.19 M(-254.9%) | -$7.25 M(+27.5%) |
| Dec 2005 | -$5.69 M(-47.9%) | $2.06 M(-212.0%) | -$5.69 M(-55.9%) |
| Sept 2005 | - | -$1.84 M(-57.1%) | -$12.90 M(-12.7%) |
| June 2005 | - | -$4.28 M(+163.6%) | -$14.78 M(+47.0%) |
| Mar 2005 | - | -$1.63 M(-68.5%) | -$10.05 M(-7.9%) |
| Dec 2004 | -$10.92 M(+58.9%) | -$5.15 M(+38.6%) | -$10.92 M(+46.6%) |
| Sept 2004 | - | -$3.72 M(-944.5%) | -$7.45 M(+29.4%) |
| June 2004 | - | $440.00 K(-117.7%) | -$5.76 M(-21.1%) |
| Mar 2004 | - | -$2.49 M(+48.1%) | -$7.30 M(+6.3%) |
| Dec 2003 | -$6.87 M(-16.7%) | -$1.68 M(-16.9%) | -$6.87 M(-22.4%) |
| Sept 2003 | - | -$2.02 M(+83.7%) | -$8.85 M(+5.8%) |
| June 2003 | - | -$1.10 M(-46.5%) | -$8.37 M(+2.0%) |
| Mar 2003 | - | -$2.06 M(-43.8%) | -$8.21 M(-0.5%) |
| Dec 2002 | -$8.25 M(+11.8%) | -$3.67 M(+137.8%) | -$8.25 M(+26.3%) |
| Sept 2002 | - | -$1.54 M(+64.9%) | -$6.53 M(-7.8%) |
| June 2002 | - | -$935.00 K(-55.6%) | -$7.09 M(-1.1%) |
| Mar 2002 | - | -$2.11 M(+7.9%) | -$7.17 M(-2.8%) |
| Dec 2001 | -$7.38 M(-1.0%) | -$1.95 M(-6.8%) | -$7.38 M(-4.0%) |
| Sept 2001 | - | -$2.09 M(+105.9%) | -$7.69 M(-4.5%) |
| June 2001 | - | -$1.02 M(-56.1%) | -$8.05 M(-6.3%) |
| Mar 2001 | - | -$2.31 M(+2.3%) | -$8.59 M(+15.3%) |
| Dec 2000 | -$7.45 M(-18.3%) | -$2.26 M(-7.9%) | -$7.45 M(-4.6%) |
| Sept 2000 | - | -$2.46 M(+57.4%) | -$7.81 M(+0.7%) |
| June 2000 | - | -$1.56 M(+33.2%) | -$7.75 M(+3.5%) |
| Mar 2000 | - | -$1.17 M(-55.3%) | -$7.49 M(-17.9%) |
| Dec 1999 | -$9.12 M(+122.4%) | -$2.62 M(+9.2%) | -$9.12 M(-11.5%) |
| Sept 1999 | - | -$2.40 M(+84.6%) | -$10.30 M(+71.7%) |
| June 1999 | - | -$1.30 M(-53.6%) | -$6.00 M(+11.1%) |
| Mar 1999 | - | -$2.80 M(-26.3%) | -$5.40 M(+31.7%) |
| Dec 1998 | -$4.10 M(-1125.0%) | -$3.80 M(-300.0%) | -$4.10 M(+51.9%) |
| Sept 1998 | - | $1.90 M(-371.4%) | -$2.70 M(-1000.0%) |
| June 1998 | - | -$700.00 K(-53.3%) | $300.00 K(-72.7%) |
| Mar 1998 | - | -$1.50 M(-37.5%) | $1.10 M(+175.0%) |
| Dec 1997 | $400.00 K(-102.9%) | -$2.40 M(-149.0%) | $400.00 K(>+9900.0%) |
| Sept 1997 | - | $4.90 M(+4800.0%) | $0.00(-100.0%) |
| June 1997 | - | $100.00 K(-104.5%) | -$5.30 M(-65.1%) |
| Mar 1997 | - | -$2.20 M(-21.4%) | -$15.20 M(+8.6%) |
| Dec 1996 | -$14.00 M(+351.6%) | -$2.80 M(+600.0%) | -$14.00 M(+12.9%) |
| Sept 1996 | - | -$400.00 K(-95.9%) | -$12.40 M(+4.2%) |
| June 1996 | - | -$9.80 M(+880.0%) | -$11.90 M(+260.6%) |
| Mar 1996 | - | -$1.00 M(-16.7%) | -$3.30 M(+6.5%) |
| Dec 1995 | -$3.10 M(-63.1%) | -$1.20 M(-1300.0%) | -$3.10 M(+10.7%) |
| Sept 1995 | - | $100.00 K(-108.3%) | -$2.80 M(-17.6%) |
| June 1995 | - | -$1.20 M(+50.0%) | -$3.40 M(-55.3%) |
| Mar 1995 | - | -$800.00 K(-11.1%) | -$7.60 M(-9.5%) |
| Dec 1994 | -$8.40 M(+15.1%) | -$900.00 K(+80.0%) | -$8.40 M(-19.2%) |
| Sept 1994 | - | -$500.00 K(-90.7%) | -$10.40 M(-21.8%) |
| June 1994 | - | -$5.40 M(+237.5%) | -$13.30 M(+54.7%) |
| Mar 1994 | - | -$1.60 M(-44.8%) | -$8.60 M(+17.8%) |
| Dec 1993 | -$7.30 M(+2333.3%) | -$2.90 M(-14.7%) | -$7.30 M(+40.4%) |
| Sept 1993 | - | -$3.40 M(+385.7%) | -$5.20 M(+225.0%) |
| June 1993 | - | -$700.00 K(+133.3%) | -$1.60 M(+77.8%) |
| Mar 1993 | - | -$300.00 K(-62.5%) | -$900.00 K(+200.0%) |
| Dec 1992 | -$300.00 K(-200.0%) | -$800.00 K(-500.0%) | -$300.00 K(-150.0%) |
| Sept 1992 | - | $200.00 K(>+9900.0%) | $600.00 K(0.0%) |
| June 1992 | - | $0.00(-100.0%) | $600.00 K(0.0%) |
| Mar 1992 | - | $300.00 K(+200.0%) | $600.00 K(+100.0%) |
| Dec 1991 | $300.00 K(-160.0%) | $100.00 K(-50.0%) | $300.00 K(+50.0%) |
| Sept 1991 | - | $200.00 K(>+9900.0%) | $200.00 K(>+9900.0%) |
| June 1991 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1991 | - | $0.00(0.0%) | -$500.00 K(0.0%) |
| Dec 1990 | -$500.00 K(-83.3%) | $0.00(0.0%) | -$500.00 K(0.0%) |
| Sept 1990 | - | $0.00(-100.0%) | -$500.00 K(0.0%) |
| June 1990 | - | -$500.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) |
| Mar 1990 | - | $0.00 | $0.00 |
| Dec 1989 | -$3.00 M | - | - |
FAQ
- What is Utah Medical Products annual cash flow from financing activities?
- What is the all time high annual CFF for Utah Medical Products?
- What is Utah Medical Products annual CFF year-on-year change?
- What is the all time high quarterly CFF for Utah Medical Products?
- What is the all time high TTM CFF for Utah Medical Products?
What is Utah Medical Products annual cash flow from financing activities?
The current annual CFF of UTMD is -$4.17 M
What is the all time high annual CFF for Utah Medical Products?
Utah Medical Products all-time high annual cash flow from financing activities is $18.08 M
What is Utah Medical Products annual CFF year-on-year change?
Over the past year, UTMD annual cash flow from financing activities has changed by +$1.32 M (+24.05%)
What is the all time high quarterly CFF for Utah Medical Products?
Utah Medical Products all-time high quarterly cash flow from financing activities is $26.85 M
What is the all time high TTM CFF for Utah Medical Products?
Utah Medical Products all-time high TTM cash flow from financing activities is $20.06 M